Radial or Focus Extracorporeal Shock Wave Therapy in Epin Calcanei
- Conditions
- Spur, Heel
- Interventions
- Device: Extracorporeal shock wave therapy
- Registration Number
- NCT06356064
- Lead Sponsor
- Ankara City Hospital Bilkent
- Brief Summary
Objective: The aim of the study was to investigate the effectiveness of radial and focused ESWT treatment on pain, function, and size of the calcaneal spur in patients with a clinical and radiological diagnosis of epin calcanei.
Methods: A total of 112 patients aged between 18 and 95 years were randomly divided into two groups: group 1 received rESWT (2.4 bar 12 hz 2000 beats), and group 2 received fESWT (0.14 bar 14 hz 1000 beats) three times a week for three weeks. All patients were evaluated using the Visual Analog Scale (VAS)-pain and Foot Function Index (FFI) before and after the treatment, at 4 weeks and 12 weeks. Epin size was measured radiographically in the patients before and after the treatment at the 12-week follow-up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 112
Not provided
- History of fracture or surgery,
- Polyneuropathy,
- Rheumatological diseases,
- Coagulation disorders,
- Tumor,
- Thrombosis,
- Soft tissue or bone infection,
- Pregnancy and lactation,
- Epilepsy,
- Presence of a pacemaker.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description rESWT( Radial Extracorporeal shock wave therapy) Extracorporeal shock wave therapy rESWT(2.4 bar, 12 hz, 2000 beats), to painful calcaneal area, three sessions, once a week, for total of three weeks fESWT(Focused Extracorporeal shock wave therapy)) Extracorporeal shock wave therapy fESWT (0.14 bar, 14 hz, 1000 beats), to painful calcaneal area, three sessions, once a week, for total of three weeks
- Primary Outcome Measures
Name Time Method Functional Foot Index Before and after treatment baseline, 4th week, 12 th week 0 is no pain 10 is max pain, and 0 is no deficiency 10 is the maximum deficiency and 0 is no activity limitation 10 is the maximum activity limitation score.
Visual Analog Scale Before and after treatment baseline, 4th week, 12 th week 0 min , 10 is maximum pain score
- Secondary Outcome Measures
Name Time Method Radiographic assesment, epin size Before and after treatment baseline, 4th week, 12 th week A decrease in the size of the epin is an indicator of recovery.
Trial Locations
- Locations (1)
Özge TEZEN
🇹🇷Ankara, Turkey